The effects of environmental neurotoxicants on the dopaminergic system: A possible role in drug addiction.

Humans are routinely exposed to a vast array of environmental neurotoxicants, including pesticides, endocrine disrupters, and heavy metals. The long-term consequences of exposure have become a major human health concern as research has indicated strong associations between neurotoxicants and a variety of dopamine-related neurological disorders. Developmental exposure to pesticides including paraquat, organochlorines, and rotenone produce alterations in the dopaminergic system and has been linked to neurodegenerative disorders, including Parkinson's disease. Endocrine disrupters such as Bisphenol A, mimic estrogenic activity and impact various dopaminergic processes to enhance mesolimbic dopamine activity resulting in hyperactivity, attention deficits, and a heightened sensitivity to drugs of abuse. A second class of endocrine disrupters, the polychlorinated biphenyls, may act directly on dopaminergic processes to disrupt the dopamine system and produce Parkinson-like symptoms. Exposure to the heavy metal lead enhances dopaminergic activity and has been associated with attention deficits, Alzheimer's disease, and increased drug sensitivity. Manganese exposure, in contrast, results in dopamine deficiencies and Parkinson-like symptoms. Therefore, this commentary will discuss the effects and consequences that exposure to these three classes of environmental neurotoxicants have on the dopamine system and related behaviors and disorders. Finally, the recent hypothesis that exposure to environmental compounds which have effects on dopaminergic neurotransmission, including 2,4-dichlorophenoxyacetic acid, Bisphenol A, and multiple heavy metals, may potentiate drug-induced behaviors and increase the brain's vulnerability to drug addiction will be discussed.

[1]  G. Hanson,et al.  Methamphetamine-induced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatment. , 2007, Addiction.

[2]  L. Rushton,et al.  Pesticides and Parkinson’s Disease—Is There a Link? , 2005, Environmental health perspectives.

[3]  M. Aschner,et al.  The effects of manganese on glutamate, dopamine and γ-aminobutyric acid regulation , 2006, Neurochemistry International.

[4]  G. Fiskum,et al.  Methoxychlor inhibits brain mitochondrial respiration and increases hydrogen peroxide production and CREB phosphorylation. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[5]  K. McDaniel,et al.  Dopamine transporter binding in the rat striatum is increased by gestational, perinatal, and adolescent exposure to heptachlor. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[6]  Y. Funae,et al.  Prenatal and neonatal exposure to bisphenol-a enhances the central dopamine d1 receptor-mediated action in mice: enhancement of the methamphetamine-induced abuse state , 2003, Neuroscience.

[7]  R. Hruska,et al.  Estrogen treatment increases the density of D1 dopamine receptors in the rat striatum , 1988, Brain Research.

[8]  N. Volkow,et al.  Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. , 2007, Addiction.

[9]  A. Levey,et al.  Heptachlor alters expression and function of dopamine transporters. , 1999, Neurotoxicology.

[10]  E. J. Nestler,et al.  Molecular neurobiology of drug addiction. , 2004, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[11]  G. Miller,et al.  Developmental exposure to the pesticide dieldrin alters the dopamine system and increases neurotoxicity in an animal model of Parkinson's disease , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  Todd B. Sherer,et al.  Mechanism of Toxicity in Rotenone Models of Parkinson's Disease , 2003, The Journal of Neuroscience.

[13]  M. Narita,et al.  Prenatal and neonatal exposure to bisphenol-A affects the morphine-induced rewarding effect and hyperlocomotion in mice , 2004, Neuroscience Letters.

[14]  A. Bortolozzi,et al.  Effects of 2,4-dichlorophenoxyacetic acid exposure on dopamine D2-like receptors in rat brain. , 2004, Neurotoxicology and teratology.

[15]  P. Eriksson,et al.  Neonatal exposure to paraquat or MPTP induces permanent changes in striatum dopamine and behavior in adult mice. , 1993, Toxicology and applied pharmacology.

[16]  S. Casteel,et al.  Dietary cadmium exposure attenuates d-amphetamine-evoked [3H]dopamine release from striatal slices and methamphetamine-induced hyperactivity , 2005, Pharmacology Biochemistry and Behavior.

[17]  C. Cavada,et al.  Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats , 2007, Experimental Neurology.

[18]  E. Richfield,et al.  Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson’s disease? , 2000, Brain Research.

[19]  D. Mash,et al.  Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities. , 1997, Brain research. Molecular brain research.

[20]  R. Kostrzewa,et al.  Maternal Lead Exposure Produces Long-Term Enhancement of Dopaminergic Reactivity in Rat Offspring , 2007, Neurochemical Research.

[21]  P. Palanza,et al.  d-Amphetamine-related reinforcing effects are reduced in mice exposed prenatally to estrogenic endocrine disruptors , 2005, Brain Research Bulletin.

[22]  G. Bratton,et al.  The effects of perinatal exposure to lead on the discriminative stimulus properties of cocaine and related drugs in rats , 2001, Psychopharmacology.

[23]  A. Esquifino,et al.  Cadmium effects on dopamine turnover and plasma levels of prolactin, GH and ACTH , 2001, Journal of Physiology and Biochemistry.

[24]  A. Krygowska-Wajs,et al.  Influence of paraquat on dopaminergic transporter in the rat brain. , 2005, Pharmacological reports : PR.

[25]  N. Volkow,et al.  Drug addiction: the neurobiology of disrupted self-control. , 2006, Trends in molecular medicine.

[26]  B. Soria,et al.  Low doses of the endocrine disruptor Bisphenol‐A and the native hormone 17β‐estradiol rapidly activate the transcription factor CREB , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  A. H. V. Schapira,et al.  MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE , 1989, The Lancet.

[28]  D. Mash,et al.  Immunochemical Analysis of Vesicular Monoamine Transporter (VMAT2) Protein in Parkinson's Disease , 1999, Experimental Neurology.

[29]  C. Roegge,et al.  Motor function following developmental exposure to PCBS and/or MEHG. , 2006, Neurotoxicology and teratology.

[30]  G. Bratton,et al.  Exposure to cadmium during gestation and lactation decreases cocaine self-administration in rats. , 2004, Neurotoxicology.

[31]  D. Mash,et al.  Dopamine transport function is elevated in cocaine users , 2002, Journal of neurochemistry.

[32]  R. Gross,et al.  Systemic exposure to paraquat and maneb models early Parkinson's disease in young adult rats , 2005, Neurobiology of Disease.

[33]  Eric K. Richfield,et al.  Overexpression of Superoxide Dismutase or Glutathione Peroxidase Protects against the Paraquat + Maneb-induced Parkinson Disease Phenotype* , 2005, Journal of Biological Chemistry.

[34]  E. Richfield,et al.  Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype. , 2002, Neurotoxicology.

[35]  M. Morita,et al.  Effects of Neonatal Treatment With 6-Hydroxydopamine and Endocrine Disruptors on Motor Activity and Gene Expression in Rats , 2004, Neural plasticity.

[36]  Dean F Wong,et al.  Acute manganese administration alters dopamine transporter levels in the non-human primate striatum. , 2006, Neurotoxicology.

[37]  E. Richfield,et al.  Developmental Pesticide Models of the Parkinson Disease Phenotype , 2005, Environmental health perspectives.

[38]  S. Faraone,et al.  Targeting the dopamine system in the treatment of attention-deficit/hyperactivity disorder , 2007, Expert review of neurotherapeutics.

[39]  M. Morita,et al.  Bisphenol A causes hyperactivity in the rat concomitantly with impairment of tyrosine hydroxylase immunoreactivity , 2004, Journal of neuroscience research.

[40]  M. Carroll,et al.  Estrogen Receptor β, but not α, Mediates Estrogen's Effect on Cocaine-Induced Reinstatement of Extinguished Cocaine-Seeking Behavior in Ovariectomized Female Rats , 2007, Neuropsychopharmacology.

[41]  F. Aboitiz,et al.  Behavioral effects of manganese injected in the rat substantia nigra are potentiated by dicumarol, a DT-diaphorase inhibitor , 2004, Pharmacology Biochemistry and Behavior.

[42]  M. Kitazawa,et al.  Dieldrin induces apoptosis by promoting caspase-3-dependent proteolytic cleavage of protein kinase Cδ in dopaminergic cells: relevance to oxidative stress and dopaminergic degeneration , 2003, Neuroscience.

[43]  A. Levey,et al.  Dopamine transporters and neuronal injury. , 1999, Trends in pharmacological sciences.

[44]  G. Bratton,et al.  Developmental Lead Exposure Alters the Stimulatory Properties of Cocaine at PND 30 and PND 90 in the Rat , 2000, Neuropsychopharmacology.

[45]  A. Levey,et al.  Striatal dopamine nerve terminal markers in human, chronic methamphetamine users , 1996, Nature Medicine.

[46]  G. Miller,et al.  Acute exposure to aroclor 1016 or 1260 differentially affects dopamine transporter and vesicular monoamine transporter 2 levels. , 2004, Toxicology letters.

[47]  F. Fonnum,et al.  The effect of polychlorinated biphenyls on the high affinity uptake of the neurotransmitters, dopamine, serotonin, glutamate and GABA, into rat brain synaptosomes. , 2001, Toxicology.

[48]  E. Richfield,et al.  The Nigrostriatal Dopaminergic System as a Preferential Target of Repeated Exposures to Combined Paraquat and Maneb: Implications for Parkinson's Disease , 2000, The Journal of Neuroscience.

[49]  T. Guilarte,et al.  Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates , 2006, Experimental Neurology.

[50]  Michael Aschner,et al.  Manganese-induced cytotoxicity in dopamine-producing cells. , 2004, Neurotoxicology.

[51]  K. Matsubara,et al.  Paraquat induces long-lasting dopamine overflow through the excitotoxic pathway in the striatum of freely moving rats , 2003, Brain Research.

[52]  P. Cooney,et al.  Brain manganese accumulation is inversely related to gamma-amino butyric acid uptake in male and female rats. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[53]  A. Bortolozzi,et al.  Behavioral alterations induced in rats by a pre- and postnatal exposure to 2,4-dichlorophenoxyacetic acid. , 1999, Neurotoxicology and teratology.

[54]  D. Cory-Slechta,et al.  Low-level lead exposure selectively enhances dopamine overflow in nucleus accumbens: an in vivo electrochemistry time course assessment. , 1998, Toxicology and applied pharmacology.

[55]  H. Rommelspacher,et al.  Degeneration of dopaminergic mesocortical neurons and activation of compensatory processes induced by a long-term paraquat administration in rats: Implications for Parkinson’s disease , 2006, Neuroscience.

[56]  C. Devi,et al.  Developmental lead exposure alters mitochondrial monoamine oxidase and synaptosomal catecholamine levels in rat brain , 2005, International Journal of Developmental Neuroscience.

[57]  M. Narita,et al.  Prenatal and neonatal exposure to low-dose of bisphenol-A enhance the morphine-induced hyperlocomotion and rewarding effect , 2006, Neuroscience Letters.

[58]  W. Shain,et al.  Lightly chlorinated ortho-substituted PCB congeners decrease dopamine in nonhuman primate brain and in tissue culture. , 1990, Toxicology and applied pharmacology.

[59]  D. Cory-Slechta Postnatal lead exposure and MK-801 sensitivity. , 1997, Neurotoxicology.

[60]  J. Yonemoto,et al.  Mesencephalic neurodegeneration in the orally administered bisphenol A-caused hyperactive rats. , 2007, Toxicology letters.

[61]  James Robert Brašić,et al.  Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users , 2008, Synapse.

[62]  G. Bratton,et al.  The effects of developmental cadmium exposure on morphine sensitization and challenge with selective D1 and D2 antagonists , 2002, Pharmacology Biochemistry and Behavior.

[63]  G. Miller Paraquat: the red herring of Parkinson's disease research. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[64]  D. Cory-Slechta,et al.  New and Evolving Concepts in the Neurotoxicology of Lead , 2007 .

[65]  P. Fumagalli,et al.  Vulnerability of mitochondrial complex I in PC12 cells exposed to manganese. , 1995, European journal of pharmacology.

[66]  Dennis K. Miller,et al.  The effects of cadmium contamination on the discriminative stimulus properties of cocaine and related drugs. , 1999, Experimental and clinical psychopharmacology.

[67]  B. Stanley,et al.  Postnatal manganese exposure attenuates cocaine-induced locomotor activity and reduces dopamine transporters in adult male rats. , 2006, Neurotoxicology and teratology.

[68]  F. Fonnum,et al.  Effect of polychlorinated biphenyls on the uptake of dopamine into rat brain synaptic vesicles: a structure-activity study. , 2001, Toxicology and applied pharmacology.

[69]  Diana Brahams,et al.  Medicine and the Law , 1983, The Lancet.

[70]  H. Tilson,et al.  Effects of polychlorinated biphenyls (PCBs) on brain tyrosine hydroxylase activity and dopamine synthesis in rats. , 1997, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[71]  G. Miller,et al.  Perinatal heptachlor exposure increases expression of presynaptic dopaminergic markers in mouse striatum. , 2005, Neurotoxicology.

[72]  T. Yen,et al.  Dopamine transporter binding in chronic manganese intoxication , 2003, Journal of Neurology.

[73]  M. Narita,et al.  Functional changes in dopamine D3 receptors by prenatal and neonatal exposure to an endocrine disruptor bisphenol‐A in mice , 2004, Addiction biology.

[74]  Y. Funae,et al.  Non‐genomic modulation of dopamine release by bisphenol‐A in PC12 cells , 2003, Journal of neurochemistry.

[75]  E. Love,et al.  Parkinson's Disease and Exposure to Rural Environmental Factors: A Population Based Case-Control Study , 1991, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[76]  P. Lein,et al.  Noncholinesterase mechanisms of chlorpyrifos neurotoxicity: altered phosphorylation of Ca2+/cAMP response element binding protein in cultured neurons. , 2002, Toxicology and applied pharmacology.

[77]  E. Unterwald,et al.  D1 dopamine receptor: A putative neurochemical and behavioral link to cocaine action , 2002, Journal of cellular physiology.

[78]  J. Silverman,et al.  Evidence for the involvement of ERβ and RGS9-2 in 17-β estradiol enhancement of amphetamine-induced place preference behavior , 2007, Hormones and Behavior.

[79]  C. D. De Rosa,et al.  Effects of polychlorinated biphenyls on the nervous system , 2000, Toxicology and industrial health.

[80]  Abby A. Li,et al.  Evaluation of Epidemiologic and Animal Data Associating Pesticides With Parkinson’s Disease , 2005, Journal of occupational and environmental medicine.

[81]  C. Davie A review of Parkinson's disease. , 2008, British medical bulletin.

[82]  P. Sokoloff,et al.  The dopamine D3 receptor and drug dependence: Effects on reward or beyond? , 2005, Neuropharmacology.

[83]  M. Suda,et al.  Effects of perinatal exposure to bisphenol A on brain neurotransmitters in female rat offspring. , 2006, Industrial health.

[84]  T. Guilarte,et al.  Manganese: recent advances in understanding its transport and neurotoxicity. , 2007, Toxicology and applied pharmacology.

[85]  E. Sabban,et al.  Transcriptional regulation of tyrosine hydroxylase by estrogen: opposite effects with estrogen receptors α and β and interactions with cyclic AMP , 2005 .

[86]  G. Bratton,et al.  Early developmental lead exposure increases sensitivity to cocaine in a self-administration paradigm , 2004, Pharmacology Biochemistry and Behavior.

[87]  A. Kurunczi,et al.  Behavioral effects of subchronic inorganic manganese exposure in rats. , 2007, American journal of industrial medicine.

[88]  K. Cunningham,et al.  Estrogen regulation of gene expression in the brain: a possible mechanism altering the response to psychostimulants in female rats. , 2002, Brain research. Molecular brain research.

[89]  S. Yajima,et al.  Regulation of striatal dopamine receptors by estrogen , 1999, Synapse.

[90]  L. Costa,et al.  Neurotoxicity of pesticides: a brief review. , 2008, Frontiers in bioscience : a journal and virtual library.

[91]  K A Frey,et al.  Striatal dopaminergic abnormalities in human cocaine users. , 1999, The American journal of psychiatry.

[92]  Gary W Miller,et al.  Paraquat neurotoxicity is distinct from that of MPTP and rotenone. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[93]  D. Cory-Slechta,et al.  Low level lead exposure increases sensitivity to the stimulus properties of dopamine D1 and D2 agonists , 1991, Brain Research.

[94]  Vellareddy Anantharam,et al.  Dieldrin-induced neurotoxicity: relevance to Parkinson's disease pathogenesis. , 2005, Neurotoxicology.

[95]  M. Aschner,et al.  Manganese exposure and induced oxidative stress in the rat brain. , 2004, The Science of the total environment.

[96]  J. Nation,et al.  Developmental exposure to cadmium alters responsiveness to cocaine in the rat. , 2003, Drug and alcohol dependence.

[97]  G. Hanson,et al.  Role of monoamine transporters in mediating psychostimulant effects , 2005, The AAPS Journal.

[98]  Myron Genel,et al.  Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents , 1998 .

[99]  F. Dick,et al.  Parkinson's disease and pesticide exposures. , 2006, British medical bulletin.